Read Full Article
Seres Therapeutics, Inc. (NASDAQ: MCRB) today announced the appointment of Willard Dere, M.D., a seasoned industry executive, to its Board of ...
Willard Dere is a highly distinguished industry leader with deep clinical development and strategic industry expertise.
Seres is advancing a promising pipeline of microbiome product candidates using a highly differentiated scientific approach. I am eager to contribute to the company's objective of bringing the first FDA approved microbiome products to individuals with serious diseases.